Skip to content

Combination of Steroids and Vitamin C to improve recovery in children with severe infection

Resuscitation in Paediatric Sepsis using Hydrocortisone and Vitamin C - A Randomized Controlled Multicentre Trial - RESPOND

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057494
Enrollment
384
Registered
2023-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R652- Severe sepsis

Interventions

Intervention1: Hydrocortisone and Vitamin C: Hydrocortisone 1mg/kg 6 hourly with Vitamin C 100mg/kg 6 hourly for upto 72 hours Control Intervention1: Hydrocortisone only: Hydrocortisone 1mg/kg 6 hourl

Sponsors

George Institute for Global Health India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Admitted to PICU 2. Decision by treating physician to treat as sepsis (including parenteral antibiotics and inortopes) 3. Treatment of septic shock with vasopressor/inotrope for >1 hour, or Vasopressor-Inotrope Score of atleast 10

Exclusion criteria

Exclusion criteria: 1. Preterm babies born 2. Palliative care patient/patient with limitation of treatment (not for Inotropes, CPR, ECLS, Intubation and Ventilation) 3. Cardiopulmonary arrest in the past 2 hours requiring CPR for >2 minutes, or death is deemed to be imminent or inevitable 4. Patients with sepsis/shock who have been treated with inotropes for >24 hours 5. Patients with known glucose-6-phosphate (G6PD)dehydrogenase deficiency 6. Patients with known history of oxale nephropathy 7. Patients with known malaria 8. Patients already receiving cyanocobalamin or Deferoxamine for their co-morbid conditions 9. Enrolment in the RESPOND study in the past 6 months

Design outcomes

Primary

MeasureTime frame
Time alive and free of vaspressorsTimepoint: Censored at 7 days

Secondary

MeasureTime frame
Alive and free of multi-organ dysfunctionTimepoint: 72 hours;Hospital length of stayTimepoint: N/A;MortalityTimepoint: N/A;Quality of lifeTimepoint: 28 days and 6 months;Survival free of cardiovascular supportTimepoint: N/A;Survival free of organ supportTimepoint: N/A;Survival free of ventilationTimepoint: N/A

Countries

Australia, Brazil, Democratic People's Republic of Korea, India

Contacts

Public ContactVivekanand Jha

George Institute for Global Health

vjha@georgeinstitute.org.in01141588091

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026